Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AFRT + Capecitabine in Pancreatic Cancer
NCT01333332Phase 2Unknown
- Sponsor
- University of Virginia
- Start
- Aug 2010
- Primary completion
- Aug 2012
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine in pancreatic ductal adenocarcinoma (PDAC), sponsored by University of Virginia. Status: unknown.
02
Drugs
capecitabine
03
Conditions
pancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT01333332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01333332.